| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/19/2000 | US6121246 Method for treating ischemic tissue |
| 09/19/2000 | US6121240 Urokinase receptor ligands |
| 09/19/2000 | US6121018 Polynucleotide which codes for polypeptide of defined amino acid sequence; for therapy and diagnosis of alzheimer's/ parkinson's diseases, multiple sclerosis, amyotrophic lateral sclerosis, septic shock, osteoporosis and other diseases |
| 09/19/2000 | US6121005 Human growth arrest specific homeobox protein; transcription factor; for treatment of postangioplasty restenosis and other cardiovascular disorders; for screening cellular partners |
| 09/19/2000 | CA2184914C Isoxazoline compounds as 5-lipoxygenase inhibitors |
| 09/19/2000 | CA2141679C New derivatives of neuraminic acid |
| 09/19/2000 | CA2071538C Hpth (1-37) fragment, its production, drug containing it and its use |
| 09/14/2000 | WO2000053749A2 Vascular adhesion molecules and modulation of their function |
| 09/14/2000 | WO2000053742A2 Polynucleotides and proteins encoded thereby |
| 09/14/2000 | WO2000053733A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 09/14/2000 | WO2000053628A2 Genes encoding human potassium channel proteins |
| 09/14/2000 | WO2000053606A1 Pyridoxal analogues for vitamin b-6 disorders |
| 09/14/2000 | WO2000053605A1 Tyrosine kinase inhibitors |
| 09/14/2000 | WO2000053604A1 Carbamoyl tetrahydropyridine derivatives |
| 09/14/2000 | WO2000053600A1 Novel piperidine derivatives |
| 09/14/2000 | WO2000053596A2 Imidazole compounds as histamine h3 ligands |
| 09/14/2000 | WO2000053566A1 Crystalline hydrated dihydroxy open-acid simvastatin calcium salt |
| 09/14/2000 | WO2000053563A1 Novel ligands of nuclear receptors ppar's |
| 09/14/2000 | WO2000053264A1 Treatment of thrombosis by combined use of a factor xa inhibitor and aspirin, tissue plasminogen activator (tpa), a gpiib/iiia antagonist, low molecular weight heparin or heparin |
| 09/14/2000 | WO2000053211A2 Method of promoting myocyte proliferation and myocardial tissue repair |
| 09/14/2000 | WO2000053204A1 A pharmaceutical composition for treating angiocardiopathy and the method of producing thereof |
| 09/14/2000 | WO2000053198A1 Inhibitor of lipoxygenase pathways |
| 09/14/2000 | WO2000053177A1 Liposome preparations |
| 09/14/2000 | WO2000053173A1 Dihydroxy open-acid and salts of hmg-co-a reductase inhibitors |
| 09/14/2000 | WO2000053168A2 Synergy between low molecular weight heparin and platelet aggregation inhibitors, for preventing and treating thromboembolic disorders |
| 09/14/2000 | WO2000037469A3 Process for preparing n6-substituted deaza-adenosine derivatives |
| 09/14/2000 | WO2000037422A3 Ion channel modulating agents |
| 09/14/2000 | WO2000035430A3 Homer a new target of treating psychiatric disorders |
| 09/14/2000 | WO2000031263A3 Gtpase associated proteins |
| 09/14/2000 | WO2000030668A8 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 09/14/2000 | WO2000030425A3 Method of using pon-1 to decrease atheroma formation |
| 09/14/2000 | WO2000026395A3 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| 09/14/2000 | WO2000004012A8 COMPOUNDS SPECIFIC FOR THE HUMAN α1d ADRENERGIC RECEPTOR AND USES THEREOF |
| 09/14/2000 | WO2000003978A3 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same |
| 09/14/2000 | WO1999063999A8 H1-histamine receptor antagonists |
| 09/14/2000 | WO1999033836A9 3'-epimeric k-252a derivatives |
| 09/14/2000 | DE19911039A1 Abgewandelte Aminosäureamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Modified amino acid amides, pharmaceutical compositions containing them and methods for their preparation |
| 09/14/2000 | CA2366644A1 Tyrosine kinase inhibitors |
| 09/14/2000 | CA2366642A1 Carbamoyl tetrahydropyridine derivatives |
| 09/14/2000 | CA2366602A1 Pyridoxal analogues for vitamin b-6 disorders |
| 09/14/2000 | CA2366281A1 Novel ligands of nuclear receptors ppar's |
| 09/14/2000 | CA2366124A1 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 09/14/2000 | CA2365869A1 Crystalline hydrated dihydroxy open-acid simvastatin calcium salt |
| 09/14/2000 | CA2364257A1 Liposome preparations |
| 09/14/2000 | CA2364253A1 Dihydroxy open-acid and salts of hmg-co-a reductase inhibitors |
| 09/14/2000 | CA2364252A1 Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders |
| 09/14/2000 | CA2362422A1 Polynucleotides and proteins encoded thereby |
| 09/14/2000 | CA2362319A1 Imidazole compounds as histamine h3 ligands |
| 09/14/2000 | CA2361849A1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/14/2000 | CA2361650A1 Treatment of thrombosis by combined use of a factor xa inhibitor and aspirin, tissue plasminogen activator (tpa), a gpiib/iiia antagonist, low molecular weight heparin or heparin |
| 09/13/2000 | EP1035131A1 Process for the preparation of n2 -(1(s)-carboxy-3-phenylpropyl)-l-lysyl-l-proline |
| 09/13/2000 | EP1035115A1 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists |
| 09/13/2000 | EP1034267A1 Compositions and methods for inducing gene expression |
| 09/13/2000 | EP1034164A1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 09/13/2000 | EP1034162A1 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
| 09/13/2000 | EP1033983A1 Cyclic amino acid derivatives as cell adhesion inhibitors |
| 09/13/2000 | EP1033974A1 High drug load immediate and modified release oral dosage formulations and processes for their manufacture |
| 09/13/2000 | EP1033910A1 Dipeptide apoptosis inhibitors and the use thereof |
| 09/13/2000 | EP0975617A4 Inhibitors of cholesterol esterase |
| 09/13/2000 | EP0871611B1 New derivatives of glycylanilides, preparation and therapeutical application |
| 09/13/2000 | EP0723439B1 Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women |
| 09/13/2000 | CN1266431A Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 09/13/2000 | CN1266429A Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same |
| 09/13/2000 | CN1266428A Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 09/13/2000 | CN1266054A Aryl carboxylic acid and tetrazole derivant |
| 09/13/2000 | CN1265915A Health-care product soluble granules made of 24 Chinese medicinal and making method thereof |
| 09/13/2000 | CN1265911A Medicine for treating cardiovascular disease and preparation process thereof |
| 09/13/2000 | CN1265905A Rhodiola rosea injection for treating angina pectoris of coronary heart disease |
| 09/13/2000 | CN1265894A Shampoo with function of depressing blood pressure and stopping headache and preparation process thereof |
| 09/13/2000 | CN1056374C Tricyclic diazepine vasopression antagonists |
| 09/13/2000 | CN1056309C Medicine for treating angiocardiopathy and cerebrovascular disease |
| 09/13/2000 | CN1056285C Medicine containing extract from flowers of salvia officinalis |
| 09/13/2000 | CN1056279C Medicinal composition for prevention and treatment of ischemic cerebral apoplexy and preparation process thereof |
| 09/12/2000 | US6117998 A1 adenosine receptor antagonists |
| 09/12/2000 | US6117912 Sublingual and buccal administration of selegiline for treating certain selegiline-responsive diseases and conditions |
| 09/12/2000 | US6117910 Bicyclic fibrinogen antagonists |
| 09/12/2000 | US6117909 Methods of using sulfamic acid derivatives for lowering serum or plasma level of Lp(a) |
| 09/12/2000 | US6117887 Inhibition of 26S and 20S proteasome by indanones |
| 09/12/2000 | US6117883 Useful for modulating a muscarinic receptor. |
| 09/12/2000 | US6117882 5-HT4 agonists and antagonists |
| 09/12/2000 | US6117881 N-cinnamoyl derivatives of (β) carbolines |
| 09/12/2000 | US6117873 Can be used for the treatment of pathological conditions which respond to blockage of excitatory amino acid receptors |
| 09/12/2000 | US6117866 For inhibiting platelet aggregation or clot formation and reocclusion of an artery or vein in a mammal following fibrinolytic therapy or angioplasty; for treating stroke, transient ischemia attacks, or myocardial infarction |
| 09/12/2000 | US6117838 Administering from about 30 to about 1,225 milligrams of intermolecularly- or intramolecularly-crosslinked stroma-free hemoglobin per kilogram of body weight to the mammal |
| 09/12/2000 | US6117445 Administration of an a1 adenosine receptor antagonist, or p2x purinoceptor or a compination of both offer potential as an antifibrotic or antisclerotic treatment |
| 09/12/2000 | CA2047773C Derivatives of benzofuran, benzothiophene, indole and indolizine, process for their preparation as well as the compositions containing them |
| 09/08/2000 | WO2000052462A1 Heart abnormalities in vascular endothelial growth factor b (vegf-b) deficient animals and methods relating to these heart abnormalities |
| 09/08/2000 | WO2000052159A1 Methods and reagents for inhibiting proliferation of smooth muscle cells |
| 09/08/2000 | WO2000052158A1 Methods and reagents for inhibiting angiogenesis |
| 09/08/2000 | WO2000052145A2 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 09/08/2000 | WO2000052051A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 09/08/2000 | WO2000052028A1 TUMOR NECROSIS FACTOR RECEPTORS 6α and 6$g(b) |
| 09/08/2000 | WO2000052007A1 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists |
| 09/08/2000 | WO2000051998A1 Compounds useful as reversible inhibitors of cathepsin s |
| 09/08/2000 | WO2000051986A1 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 09/08/2000 | WO2000051981A1 Aminocycloalkyl cinnamide compounds for arrhythmia and as analgesics and anesthetics |
| 09/08/2000 | WO2000051979A1 C16 unsaturated fp-selective prostaglandins analogs |
| 09/08/2000 | WO2000051971A1 Oxamic acids and derivatives as thyroid receptor ligands |
| 09/08/2000 | WO2000051968A1 Method for the preparation of a chiral-beta-amino ester |
| 09/08/2000 | WO2000051686A1 Use of integrin antagonist and a chemotherapeutic agent in the treatment of neoplasia |